China National Pharmaceutical Group: The revenue in the first quarter of 2026 was 17.823 billion yuan, a year-on-year decrease of 12.36% in net profit.

China National Pharmaceutical Group announced that in the first quarter of 2026, the company achieved operating income of 17.823 billion yuan, a decrease of 2.57% year-on-year; net profit attributable to shareholders of the listed company was 287 million yuan, a decrease of 12.36% year-on-year. The distribution sector had operating income of 13.356 billion yuan, a decrease of 1.72% year-on-year, and a net profit of 199 million yuan, a decrease of 13.60% year-on-year; the retail sector had operating income of 4.739 billion yuan, a decrease of 4.89% year-on-year, and a net profit of 50 million yuan, an increase of 15.42% year-on-year.